Target intelligence / Profile preview

Multiple cytokine and neurotrophic signaling pathways

Molecular classification
Signaling pathway, Biological process
01

Overview

Multiple cytokine and neurotrophic signaling pathways represent a broad regulatory network that integrates immune system signals with neuronal growth and survival factors. Cytokines, such as interleukins and interferons, typically mediate inflammatory responses, while neurotrophic factors like brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) support the development and maintenance of the nervous system (Duman & Monteggia, 2006, PubMed: 16531991). These pathways are deeply interconnected; for instance, chronic neuroinflammation driven by pro-inflammatory cytokines can suppress neurotrophic support, leading to neurodegeneration or psychiatric disorders like major depression (Miller et al., 2009, PubMed: 19426289). Drugs targeting these pathways, such as Cerebrolysin or certain pleiotropic antidepressants, often aim to exert neuroprotective effects by either inhibiting inflammatory signaling or enhancing neurotrophic signaling (Plosker & Gauthier, 2012, PubMed: 22512327). Because this 'target' encompasses a wide array of receptors and intracellular messengers rather than a single molecular entity, it is considered a descriptive category of biological processes rather than a specific therapeutic target. Therapeutic intervention in these pathways requires careful calibration to restore homeostatic balance in the central nervous system without causing broad systemic side effects.

Other names
Neuro-immune signaling axisCytokine-neurotrophin crosstalkNeurotrophic and inflammatory signaling networks
02

Mechanism of action

Modulation of diverse intracellular signaling cascades, such as the JAK/STAT, PI3K/Akt, and MAPK/ERK pathways, to balance pro-inflammatory signals and enhance neurotrophic support.

03

Biological functions

Signal transductionNeuroprotectionImmune responseCell survivalSynaptic plasticityNeurogenesis
04

Disease associations

Neurodegenerative diseaseMajor depressive disorderAlzheimer's diseaseMultiple sclerosisChronic inflammationStroke
05

Safety considerations

Systemic immunosuppressionPleiotropic off-target effectsPotential for tumorigenesis due to growth factor overstimulationComplex drug-drug interactions
06

Interacting drugs

Cerebrolysin

5 more in the full profile.

07

Biomarkers

Brain-derived neurotrophic factor (BDNF)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Nerve growth factor (NGF)C-reactive protein (CRP)

Beyond the preview

Go deeper on Multiple cytokine and neurotrophic signaling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple cytokine and neurotrophic signaling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call